Abstract:Abstract Background In preclinical human Alzheimer’s disease (AD), novelty‐related functional connectivity of the locus coeruleus (LC) with the medial temporal lobe (MTL) (Conn LC‐MTL ) predicted beta‐amyloid (Aβ)‐related longitudinal cognitive decline. In animals, LC lesions in AD models led to dwindling LC projections to the hippocampus, hippocampal atrophy, and cognitive impairment. Following these observations, we investigated the contribution of cross‐sectional and longitudinal atrophy in early Braak stages as a potential mechanism underlying this relationship. Method We included 128 participants of the Harvard Aging Brain Study (HABS) with baseline Pittsburgh Compound‐B Positron Emission Tomography – Distribution Volume Ratio (PiB PET, DVR; 36 Aβ+), as well as baseline functional and longitudinal structural MRI (n tot = 372; ∼ every 3 years; follow‐up 5±3.4 years) and yearly cognitive assessments (PACC5 = Preclinical Alzheimer’s Cognitive Composite; n tot = 874; follow‐up 6.5±3.3 years) (Table 1). Conn LC‐MTL values were derived voxel‐wise and averaged across significant clusters. FreeSurfer‐estimated cortical thickness and hippocampus/amygdala volume (adjusted for intracranial volume) were z‐scored and averaged in two variables (THV 2 /THV 3 ), encompassing regions associated with Braak stage II and III respectively (Table 1). Baseline associations were evaluated with linear models, longitudinal relationships between Conn LC‐MTL and THV 2 /THV 3 with mixed‐effects models (random intercept and slope). Mediation of Conn LC‐MTL and PACC5 slopes (year 5‐13) by THV 2 /THV 3 slopes (year 0‐5) was calculated (n = 79; bootstrapped n = 1000; Table 1). All models contained age, sex and education as covariates. Result At baseline, Conn LC‐MTL positively associated with THV 2 (p = 0.005) and with PACC5 (p = 0.045), but not with THV 3 (p = 0.26; Figure 1A‐C). Longitudinally, Conn LC‐MTL did not predict changes in THV 2 nor THV 3 . However, we observed faster cortical atrophy with lower Conn LC‐MTL at higher levels of neocortical PiB (THV 2 : p = 0.02; THV 3 : p<0.001; Figure 1D‐E). Finally, THV 2 , but not THV 3 , mediated the relationship between Conn LC‐MTL and PACC5 decline (p = 0.024) and this effect was stronger in PiB+ individuals compared to PiB‐ (p = 0.026; Figure 2). Conclusion Worse LC‐MTL connectivity was associated with downstream atrophy in the target Braak‐stage II areas, which impacted cognitive performance in preclinical AD. Given that in similar previous animal findings activation of the norepinephrine LC system reversed memory deficits, maintaining optimal Conn LC‐MTL may be a promising intervention target to delay disease progression.

Elevated locus coeruleus metabolism provides resilience against cognitive decline in preclinical Alzheimer's disease

Temporal Dynamic Changes of Intrinsic Brain Activity Associated with Cognitive Reserve in Prodromal Alzheimer's Disease.

Locus coeruleus metabolic changes as a predictor of tau accumulation and cognitive decline

Locus coeruleus integrity and left frontoparietal connectivity provide resilience against attentional decline in preclinical alzheimer's disease

Left Frontoparietal Connectivity Counteracts Locus Coeruleus‐Related Attentional Decline in Preclinical Alzheimer’s Disease

Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease

Lower novelty-related locus coeruleus function is associated with Aβ-related cognitive decline in clinically healthy individuals

Spatiotemporal Assessment of Locus Coeruleus Integrity Predicting Cortical Tau and Cognition

Lower novelty‐related locus coeruleus function is associated with entorhinal tau‐mediated memory decline in older individuals.

Atrophy links lower novelty‐related locus coeruleus connectivity to cognitive decline in preclinical AD

Lower Locus Coeruleus Integrity Signals Elevated Entorhinal Tau and Clinical Progression in Asymptomatic Older Individuals

Braak‐stage II atrophy links lower locus coeruleus – medial temporal lobe connectivity to cognitive decline in preclinical AD

Association of Novelty-Related Locus Coeruleus Function With Entorhinal Tau Deposition and Memory Decline in Preclinical Alzheimer Disease

MRI‐assessed locus coeruleus integrity is heritable and associated with multiple cognitive domains, mild cognitive impairment, and daytime dysfunction

Higher Cognitive Reserve Is Beneficial for Cognitive Performance Via Various Locus Coeruleus Functional Pathways in the Pre-Dementia Stage of Alzheimer's Disease

Locus coeruleus in memory formation and Alzheimer's disease

In vivo and neuropathology data support locus coeruleus integrity as indicator of Alzheimer’s disease pathology and cognitive decline

Topographic extent of cerebral hypometabolism predicts time of conversion from aMCI to Alzheimer's disease: Data from the Alzheimer's Disease Neuroimaging Initiative

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI

Longitudinal brain metabolic changes from amnestic mild cognitive impairment to Alzheimer's disease

The Cortical Glucose Metabolism Signatures of Cognitive Resilience in Amyloid Positive Cognitively Unimpaired Elderly Adults